Efficacy and safety profile of phosphodiesterase 4 inhibitor in the treatment of psoriasis: A systematic review and meta-analysis of randomized controlled trials

Overview of attention for article published in Frontiers in immunology, October 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 19 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 59,982 followers.

Efficacy and safety profile of phosphodiesterase 4 inhibitor in the treatment of psoriasis: A systematic review and meta-analysis of randomized controlled trials https://t.co/eUaNbI6AmQ

27 Oct 2022

Reply Repost Favourite

Efficacy and safety profile of phosphodiesterase 4 inhibitor in the treatment of psoriasis: A systematic review and meta-analysis of randomized controlled trials: Background Systemic therapy is an important treatment for… #immunology https://t.co/g0DuztUe

11 Oct 2022

Reply Repost Favourite

RT @FrontImmunol: New Research: Efficacy and safety profile of phosphodiesterase 4 inhibitor in the treatment of psoriasis: A systematic re…

10 Oct 2022

Reply Repost Favourite

New Research: Efficacy and safety profile of phosphodiesterase 4 inhibitor in the treatment of psoriasis: A systematic review and meta-analysis of randomized controlled trials: Background Systemic therapy is an important treatment for… https://t.co/L7wKW4

10 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.